EHA Library - The official digital education library of European Hematology Association (EHA)

FOCAL ERG DELETIONS AND DUX4 FUSIONS IN CELL LINES DERIVED FROM B CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Author(s): ,
Hilmar Quentmeier
Affiliations:
DSMZ,Braunschweig,Germany
,
Roderick AF MacLeod
Affiliations:
DSMZ,Braunschweig,Germany
,
Claudia Pommerenke
Affiliations:
DSMZ,Braunschweig,Germany
Hans G Drexler
Affiliations:
DSMZ,Braunschweig,Germany
(Abstract release date: 05/18/17) EHA Library. Quentmeier H. 05/18/17; 182337; PB1623
Hilmar Quentmeier
Hilmar Quentmeier
Contributions
Abstract

Abstract: PB1623

Type: Publication Only

Background
DUX4 has recently been presented as new oncogenic driver in B cell acute lymphoblastic leukemia (pre B-ALL) of adolescents and young adults [1]. Translocations of DUX4, especially those with the IGH locus led to high expression of the corresponding fusion gene. DUX4 then triggered the expression or a novel isoform of the ETS transcription factor ERG in pre B-ALL [2]. Focal deletions of exons 3-9 were a second cause for short ERG variants. Up to 7% of pre B-ALL showed deregulated expression of both genes, DUX4 and ERG [2].

Aims
We set out to find pre B-ALL cell lines with DUX4 translocation and ERG deletion as potential model systems for this novel subtype of pre B-ALL.

Methods
We screened a panel of ALL cell lines for aberrant expression of DUX4 mRNA as potential indicator for DUX4 translocations. Genomic PCR was performed to detect focal ERG deletions, qRT-PCR showed expression of alternative ERG exon 6, transcriptional target of DUX4.

Results
Genomic PCR showed that 2/66 pre B-ALL cell lines (NALM-6, SUP-B15) tested carried deletions targeting ERG exon 5. Results of DUX4 qRT-PCR (Taqman probe Hs03037979_g1) were surprisingly inconsistent with Western blot analysis - which could only in part be explained by DUX4 being a one-exon gene. NALM-6 was the only cell line expressing the DUX4 protein. Likewise, the alternative ERG transcript with alternative exon 6 was observed in NALM-6 only.

Conclusion

In conclusion, focal ERG deletions in pre B-ALL cell lines (2/66) occur at similar frequencies as in the primary tumor. Cell line NALM-6 carries the DUX4-IHG translocation, expresses the DUX4 protein and an ERG mRNA variant including the alternative exon 6. ERG deletions were present in cell lines NALM-6 and SUP-B15. However, cell line SUP-B15 did not express DUX4 protein and consequently also not alternative ERG exon 6 transcript. These results indicate that focal ERG deletions are not a safe indicator for aberrant expression of DUX4. Cell line NALM-6 is presented as model system for DUX4/ERG pre B-ALL.
1 Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nature Genetics 2016;48: 549-574.
2 Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, et al. Deregulaton of DUX4 and ERG in acute lymphoblastic leukemia. Nature Genetics 2016;48: 1481-1489.

Session topic: 1. Acute lymphoblastic leukemia - Biology

Keyword(s): B cell acute lymphoblastic leukemia, ALL

Abstract: PB1623

Type: Publication Only

Background
DUX4 has recently been presented as new oncogenic driver in B cell acute lymphoblastic leukemia (pre B-ALL) of adolescents and young adults [1]. Translocations of DUX4, especially those with the IGH locus led to high expression of the corresponding fusion gene. DUX4 then triggered the expression or a novel isoform of the ETS transcription factor ERG in pre B-ALL [2]. Focal deletions of exons 3-9 were a second cause for short ERG variants. Up to 7% of pre B-ALL showed deregulated expression of both genes, DUX4 and ERG [2].

Aims
We set out to find pre B-ALL cell lines with DUX4 translocation and ERG deletion as potential model systems for this novel subtype of pre B-ALL.

Methods
We screened a panel of ALL cell lines for aberrant expression of DUX4 mRNA as potential indicator for DUX4 translocations. Genomic PCR was performed to detect focal ERG deletions, qRT-PCR showed expression of alternative ERG exon 6, transcriptional target of DUX4.

Results
Genomic PCR showed that 2/66 pre B-ALL cell lines (NALM-6, SUP-B15) tested carried deletions targeting ERG exon 5. Results of DUX4 qRT-PCR (Taqman probe Hs03037979_g1) were surprisingly inconsistent with Western blot analysis - which could only in part be explained by DUX4 being a one-exon gene. NALM-6 was the only cell line expressing the DUX4 protein. Likewise, the alternative ERG transcript with alternative exon 6 was observed in NALM-6 only.

Conclusion

In conclusion, focal ERG deletions in pre B-ALL cell lines (2/66) occur at similar frequencies as in the primary tumor. Cell line NALM-6 carries the DUX4-IHG translocation, expresses the DUX4 protein and an ERG mRNA variant including the alternative exon 6. ERG deletions were present in cell lines NALM-6 and SUP-B15. However, cell line SUP-B15 did not express DUX4 protein and consequently also not alternative ERG exon 6 transcript. These results indicate that focal ERG deletions are not a safe indicator for aberrant expression of DUX4. Cell line NALM-6 is presented as model system for DUX4/ERG pre B-ALL.
1 Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nature Genetics 2016;48: 549-574.
2 Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, et al. Deregulaton of DUX4 and ERG in acute lymphoblastic leukemia. Nature Genetics 2016;48: 1481-1489.

Session topic: 1. Acute lymphoblastic leukemia - Biology

Keyword(s): B cell acute lymphoblastic leukemia, ALL

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies